Lv3
298 积分 2025-10-05 加入
Editorial: Does Metabolic Dysfunction‐Associated Steatotic Liver Disease With Advanced Fibrosis Also Equate to Risk of Advanced Coronary Artery Disease? Authors' Reply
11天前
已完结
Recompensation in MASLD-related cirrhosis via metabolic bariatric surgery
17天前
已完结
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study
17天前
已完结
Global Burden of Major Chronic Liver Diseases in 2021
17天前
已完结
From “Burnt-Out” to “Burning-Out”: Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction–Associated Steatotic Liver Disease From a Dynamic Perspective
17天前
已完结
Association of Plasma Lipoprotein(a) With Major Adverse Cardiovascular Events in MASLD With or Without Advanced Liver Fibrosis
17天前
已完结
Statins in MASLD: Challenges and future directions
17天前
已关闭
Non-invasive tests of fibrosis in the management of MASLD: revolutionising diagnosis, progression and regression monitoring
17天前
已完结
Association between longitudinal weight change and clinical outcome in individuals with MASLD
17天前
已完结
皖公网安备34019202002308
